MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Marketable securities$407,348K Cash and cashequivalents$111,826K Prepaid expenses andother current assets$11,141K Total current assets$530,315K Long-term marketablesecurities$62,747K Non-current clinicaldeposits$13,318K Operating leaseright-of-use assets$10,170K Other non-currentassets$5,591K Property and equipment,net$1,854K Restricted cash$761K Total assets$624,756K Accumulated deficit-$447,533K Accumulated othercomprehensive (loss) income-$532K Total liabilities,convertible preferred stock...$624,756K Total stockholders'deficit-$432,088K Additional paid-in capital$15,977K Convertible preferredstock-Series BConvertible...$602,058K Convertible preferredstock-Series AConvertible...$390,306K Total liabilities$64,480K Total currentliabilities$54,836K Operating leaseliabilities, non-current$9,443K Other non-currentliabilities$201K Accrued expenses andother current...$46,714K Accounts payable$7,095K Operating leaseliabilities, current$1,027K
Balance Sheet

Kailera Therapeutics, Inc. (KLRA)

Kailera Therapeutics, Inc. (KLRA)

source: myfinsight.com